Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study).
Adolescent
Adult
Aged
Aged, 80 and over
Bacteremia
/ epidemiology
Community-Acquired Infections
/ epidemiology
Cross Infection
/ epidemiology
Escherichia coli
/ isolation & purification
Female
Humans
Klebsiella
/ isolation & purification
Male
Middle Aged
Prospective Studies
Risk Factors
Severity of Illness Index
Spain
/ epidemiology
Staphylococcus aureus
/ isolation & purification
Young Adult
Aetiology
Bacteraemia
Bloodstream infection
Epidemiology
Healthcare-associated
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
13
10
2020
revised:
02
03
2021
accepted:
24
04
2021
pubmed:
8
5
2021
medline:
29
10
2021
entrez:
7
5
2021
Statut:
ppublish
Résumé
The epidemiology of bloodstream infections (BSIs) is dynamic as it depends on microbiological, host and healthcare system factors. The aim of this study was to update the information regarding the epidemiology of BSIs in Spain considering the type of acquisition. An observational, prospective cohort study in 26 Spanish hospitals from October 2016 through March 2017 including all episodes of BSI in adults was performed. Bivariate analyses stratified by type of acquisition were performed. Multivariate analyses were performed by logistic regression. Overall, 6345 BSI episodes were included; 2510 (39.8%) were community-acquired (CA), 1661 (26.3%) were healthcare-associated (HCA) and 2056 (32.6%) hospital-acquired (HA). The 30-day mortality rates were 11.6%, 19.5% and 22.0%, respectively. The median age of patients was 71 years (interquartile range 60-81 years) and 3656 (58.3%; 95% confidence interval 57.1-59.6%) occurred in males. The proportions according to patient sex varied according to age strata. Escherichia coli (43.8%), Klebsiella spp. (8.9%), Staphylococcus aureus (8.9%) and coagulase-negative staphylococci (7.4%) were the most frequent pathogens. Multivariate analyses confirmed important differences between CA and HCA episodes, but also between HCA and HA episodes, in demographics, underlying conditions and aetiology. In conclusion, we have updated the epidemiological information regarding patients' profiles, underlying conditions, frequency of acquisition types and aetiological agents of BSI in Spain. HCA is confirmed as a distinct type of acquisition.
Identifiants
pubmed: 33961992
pii: S0924-8579(21)00094-7
doi: 10.1016/j.ijantimicag.2021.106352
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
106352Informations de copyright
Copyright © 2021 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.